Windtree Therapeutics Inc
WINT
WINT was delisted on the 4th of May, 2017.
73 hedge funds and large institutions have $117M invested in Windtree Therapeutics Inc in 2014 Q1 according to their latest regulatory filings, with 19 funds opening new positions, 18 increasing their positions, 17 reducing their positions, and 5 closing their positions.
280% more first-time investments, than exits
New positions opened: 19 | Existing positions closed: 5
66% more call options, than puts
Call options by funds: $636K | Put options by funds: $383K
22% more funds holding
Funds holding: 60 → 73 (+13)
6% more repeat investments, than reductions
Existing positions increased: 18 | Existing positions reduced: 17
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0% less capital invested
Capital invested by funds: $117M → $117M (-$561K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TCM
Tamarack Capital Management
Carlsbad,
California
|
+$1.81M |
| 2 |
TI
Turner Investments
Berwyn,
Pennsylvania
|
+$1.48M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
+$1.44M |
| 4 |
Alyeska Investment Group
Chicago,
Illinois
|
+$1.31M |
| 5 |
BIT
BlackRock Institutional Trust
San Francisco,
California
|
+$899K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wells Fargo
San Francisco,
California
|
-$3.26M |
| 2 |
Millennium Management
New York
|
-$1.46M |
| 3 |
D.E. Shaw & Co
New York
|
-$765K |
| 4 |
SM
Sabby Management
Miami Beach,
Florida
|
-$693K |
| 5 |
TC
TFS Capital
West Chester,
Pennsylvania
|
-$665K |
WINT Hedge Fund Activity: Q1 2014 in Review
73 of the 3,464 institutional investors tracked by Wall St. Rank reported a position in Windtree Therapeutics Inc (WINT) for Q1 2014, worth a combined $117M — down 0.48% from $117M a quarter earlier.
Buyers outnumbered sellers: 19 funds opened new WINT positions and 5 closed out — a net gain of 14 holders — while 18 added to existing stakes and 17 trimmed.
The largest buyer was Tamarack Capital Management, adding an estimated $1.81M. The largest seller was Wells Fargo, cutting an estimated $3.26M.
- 73 institutional investors held Windtree Therapeutics Inc (WINT) as of Q1 2014, up from 60 in Q4 2013.
- Funds reported $117M of Windtree Therapeutics Inc stock for Q1 2014, down 0.48% quarter-over-quarter.
- 19 funds opened new Windtree Therapeutics Inc positions in Q1 2014 and 5 closed out, a net change of +14 holders.
- The largest Windtree Therapeutics Inc buyer in Q1 2014 was Tamarack Capital Management, an estimated $1.81M added.
- The largest Windtree Therapeutics Inc seller in Q1 2014 was Wells Fargo, an estimated $3.26M sold.
Based on aggregated 13F filings for Q1 2014.